Security key
83006G401
60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SXTP)
CUSIP: 83006G401
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 44,358
- Total 13F value
- $22,547
- Share change
- +1,763
- SEC-reported price per share
- $0.51
- Number of holders
- 7
- Value change
- -$23,782
- Number of buys
- 4
- Number of sells
- 2
- Shares outstanding
- 4,285,676
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
7
Top holders
7
SXTP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
60 DEGREES PHARMACEUTICALS, INC. SEC filings
60 DEGREES PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83006G401
Recent filing periods:
Ownership snapshot
Top reported holders of SXTP - 60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CVI Investments, Inc.
Disclosed value leader
Knight Therapeutics Inc.
Comparable rows
11/15
Latest evidence
30 Sep 2025
13D/G
3/4/5
13F
Lead comparable stake: 9.9%
4 rows are not safely comparable across share classes.
13D/G row: CVI Investments, Inc.
Showing 1-6 of 15 holder rows.
Quick read
CVI Investments, Inc. leads the comparable SEC ownership view at 9.9%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CVI Investments, Inc.'s linked filing trail.
Comparable ownership
Top 5
CVI Investments, Inc.
9.9%
ARMISTICE CAPITAL, LLC
5%
Orca Capital AG
4.9%
Ayrton Capital LLC
4.1%
Cheryl Xu
0.37%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
9.9%
|
$670,061
455,545 shares
|
+$187,456 | 30 Sep 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$226,656
77,357 shares
|
$0 | 31 Mar 2025 |
| Orca Capital AG |
13D/G
|
4.9%
|
$382,327
166,229 shares
|
$0 | 15 Jul 2025 |
| Ayrton Capital LLC |
13D/G
|
4.1%
|
$260,977
177,427 shares
|
+$20,515 | 30 Sep 2025 |
| Cheryl Xu |
3/4/5
Director
|
0.37%
|
$45,866
15,816 shares
|
— | 03 Jun 2025 |
| DRW Securities, LLC |
13F
Company
|
0.59%
|
$37,312
25,211 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
44,358
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
7
Q4 2025 holders
7
Holder diff
0
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend